Document Detail

Laser therapy and pain-related behavior after injury of the inferior alveolar nerve: possible involvement of neurotrophins.
MedLine Citation:
PMID:  23190308     Owner:  NLM     Status:  MEDLINE    
Nerve-related complications have been frequently reported in dental procedures, and a very frequent type of occurrence involves the inferior alveolar nerve (IAN). The nerve injury in humans often results in persistent pain accompanied by allodynia and hyperalgesia. In this investigation, we used an experimental IAN injury in rats, which was induced by a Crile hemostatic clamp, to evaluate the effects of laser therapy on nerve repair. We also studied the nociceptive behavior (von Frey hair test) before and after the injury and the behavioral effects of treatment with laser therapy (emitting a wavelength of 904 nm, output power of 70 Wpk, a spot area of ∼0.1 cm², frequency of 9500 Hz, pulse time 60 ns and an energy density of 6 J/cm²). As neurotrophins are essential for the process of nerve regeneration, we used immunoblotting techniques to preliminarily examine the effects of laser therapy on the expression of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF). The injured animals treated with laser exhibited an improved nociceptive behavior. In irradiated animals, there was an enhanced expression of NGF (53%) and a decreased BDNF expression (40%) after laser therapy. These results indicate that BDNF plays a locally crucial role in pain-related behavior development after IAN injury, increasing after lesions (in parallel to the installation of pain behavior) and decreasing with laser therapy (in parallel to the improvement of pain behavior). On the other hand, NGF probably contributes to the repair of nerve tissue, in addition to improving the pain-related behavior.
Daniel de Oliveira Martins; Fabio Martinez dos Santos; Mara Evany de Oliveira; Luiz R G de Britto; José Benedito Dias Lemos; Marucia Chacur
Related Documents :
2583998 - The relationship of electromyographic and vasomotor activity to mmpi subgroups in chron...
20352588 - Trigeminal autonomic cephalalgias: paroxysmal hemicrania, sunct/suna, and hemicrania co...
19178578 - Early responses in randomized clinical trials of triptans in acute migraine treatment. ...
18377378 - Predictors of disability in migraineurs referred to a tertiary clinic: neck pain, heada...
22686618 - Apixaban: a review of its use in the prevention of venous thromboembolism after knee or...
16359798 - Referred pain and hyperalgesia in human tendon and muscle belly tissue.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2013-03-20
Journal Detail:
Title:  Journal of neurotrauma     Volume:  30     ISSN:  1557-9042     ISO Abbreviation:  J. Neurotrauma     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-04-17     Completed Date:  2014-01-21     Revised Date:  2014-03-26    
Medline Journal Info:
Nlm Unique ID:  8811626     Medline TA:  J Neurotrauma     Country:  United States    
Other Details:
Languages:  eng     Pagination:  480-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Brain-Derived Neurotrophic Factor / biosynthesis*
Laser Therapy, Low-Level / methods*
Mandibular Nerve / metabolism*
Nerve Growth Factor / biosynthesis*
Nerve Growth Factors / biosynthesis
Pain / metabolism*
Pain Management / methods
Rats, Wistar
Trigeminal Nerve Injuries / metabolism*,  therapy
Reg. No./Substance:
0/Brain-Derived Neurotrophic Factor; 0/Nerve Growth Factors; 9061-61-4/Nerve Growth Factor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Electrophysiological Properties of the Microstome and Macrostome Morph of the Polymorphic Ciliate Te...
Next Document:  Image-guided biopsy of small renal masses in the era of ablative therapies.